Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholesterol-Lowering Atherosclerosis Study (CLAS)

NCT00000599 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00000599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholesterol-Lowering Atherosclerosis Study (CLAS)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1980
Completion date
November 30, 1994
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, atherosclerosis, cardiovascular diseases, carotid artery diseases, cerebral arteriosclerosis, cerebrovascular disorders, coronary arteriosclerosis, coronary disease, heart diseases, myocardial ischemia